Jubilant Life Sciences’ pharma and life science ingredients businesses will demerge from tomorrow.
The company had announced this demerger for reasons such as focus on separate entities, capital allocation etc., and this demerged life sciences business will be listed on the exchanges a couple of weeks later with a mirror shareholding.
Jubilant Life Sciences is also changing the name of the pharmaceutical business to Jubilant Pharmova, which will be the residual business tomorrow onwards.
Watch accompanying vide of CNBC-TV18’s Ekta Batra for more details